Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Diverticulitis Disease Market Size Shifted, And What Is the Outlook Through 2034?
In recent times, the market size for diverticulitis disease has seen robust growth. The market is expected to expand from $1.85 billion in 2024 to $2.02 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The notable growth in the historic period can be credited to factors such as an aging population, changing dietary habits, obesity issues, and improvements in medical imaging.
In the ensuing years, the diverticulitis disease market is anticipated to witness robust expansion. The market is projected to escalate to$2.91 billion in 2029″ with a compound annual growth rate (CAGR) of 9.5%. The growth during the forecast period could be ascribed to factors like colonoscopy and endoscopy, heightened awareness, minimally invasive procedures, and personalized medicine. Key trends in the forecast period involve preventive strategies, improved diagnostic tools, cooperative care models, and modifications in healthcare policies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp
What are the Fundamental Drivers and Innovations Shaping the Diverticulitis Disease Market?
An uptick in smoking addiction, fueled by targeted advertising, societal acceptance, stress, and nicotine’s addictive properties, is projected to accelerate the diverticulitis disease market’s expansion. The increase in smoking addiction can also be attributed to the presence of e-cigarettes and vape gadgets, and susceptibility to societal cues and peer pressure, particularly amongst younger people. Smoking raises the possibility of developing diverticular disease by restricting blood flow to the colon, potentially resulting in serious complications and increasing the demand for diagnosis and treatment options. For example, Statistics Canada, a government agency, reported in July 2022 that cigarette production had risen by 5.8% in comparison to June 2021. Additionally, the total number of cigarettes sold was higher by 1.3% from May 2022, culminating in 1.4 billion by June 2022. Hence, the escalating prevalence of smoking addiction is predicted to boost the diverticulitis disease market’s growth.
How Is the Diverticulitis Disease Market Segmented?
The diverticulitis diseasemarket covered in this report is segmented –
1) By Type: Uncomplicated; Complicated
2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test
3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids
4) By End-User: Specialty Centers; Hospitals; Research centers
Subsegments:
1) By Uncomplicated: Outpatient Treatment; Dietary Management; Antibiotic Therapy
2) By Complicated: Hospitalization; Surgical Intervention; Intravenous Antibiotics; Abscess Drainage
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp
Which Regions Are Driving the Next Phase of the Diverticulitis Disease Market Growth?
North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Key Trends Are Shaping the Future of the Diverticulitis Disease Market?
The major players in the market for diverticulitis disease are focusing on creating innovative drugs and securing their approval in order to maintain their standing. The creation of these drugs can result in more effective diverticulitis treatments, decrease the possibility of complications, and enhance patient outcomes. For example, in April 2023, Seres’ microbiota drug for repeat gut infections received approval from the United States Food and Drug Administration, a federal organization located in the US. This medication, which is aimed at treating repeat gut infections and preventing an additional occurrence of Clostridioides difficile (C. diff.) infections in adults over 18, gained approval for Vowst based on a clinical trial involving 346 patients with recurrent CDI. The study indicated that those who were given Vowst were considerably less likely to have a repeat of the infection than those given a placebo. This orally-administered drug is rooted in microbiota containing Firmicutes spores, which are recognized for promoting a healthy microbiome resistant to C. diff. colonization.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report
How Is the Diverticulitis Disease Market Defined and What Are Its Core Parameters?
Diverticulitis disease refers to a medical condition characterized by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. The symptoms of diverticular disease include lower abdominal pain, constipation, diarrhea and rectal bleeding.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12990
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model